Optimizing liposomal drug release via γ-irradiation and iron-based radiosensitization

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Radiochemistry

Background:

• Chemotherapy lacks tumor specificity, causing systemic toxicity and limiting dosage.
• Current radiation-responsive nanocarriers have insufficient drug release at clinical radiation doses.
• Previous liposomal formulations showed limited, non-rapid release and incompatibility with remote loading.

Purpose of the Study:

• To optimize liposomal membrane composition for enhanced radiation sensitivity and stability.
• To develop a novel radiosensitization mechanism for triggered drug release.
• To improve localized drug delivery in irradiated tumors, minimizing off-target effects.

Main Methods:

• Modulation of liposomal membrane composition using polyunsaturated and saturated phospholipids.
• Encapsulation of Fe³⁺ ions within liposomes for iron-mediated oxidative activation.
• Evaluation of drug release kinetics upon exposure to gamma (γ)-irradiation.

Main Results:

• Optimized liposomes demonstrated enhanced radiation sensitivity and improved colloidal stability.
• Iron ion reduction to Fe²⁺ upon γ-irradiation triggered a Fenton-like reaction.
• This mechanism induced localized lipid peroxidation and liposomal membrane disruption, leading to significantly enhanced drug release at low radiation doses.

Conclusions:

• The dual strategy of membrane tuning and iron-mediated activation significantly enhances radiation-induced drug release from liposomes.
• This approach offers a promising platform for targeted chemotherapy delivery in cancer treatment.
• Further development could lead to more effective and less toxic cancer therapies.